A major drugmaker will argue Wednesday that the government price-setting program created to slash prescription drug costs was unlawfully implemented.
Among the nine ongoing lawsuits filed against the Biden administration, AstraZeneca’s approach to striking down the pricing scheme poses unique arguments compared to the ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.